Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Doxorubicin-induced cardiac mitochondrionopathy
Kendall B. Wallace
Biomedical Sciences
Research output
:
Contribution to journal
›
Short survey
›
peer-review
334
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Doxorubicin-induced cardiac mitochondrionopathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Doxorubicin
100%
Leukemia
20%
Solid Tumors
20%
Long-term Treatment
20%
Calcium Regulation
20%
Dilated Cardiomyopathy
20%
Cell Targeting
20%
Drug Exposure
20%
Cardiac Failure
20%
High Incidence
20%
Radical Intermediates
20%
Free Radicals
20%
Cytopathology
20%
Redox Cycling
20%
Adriamycin
20%
Cardiac Mitochondria
20%
Antineoplastic Agents
20%
Intracellular Targets
20%
Cell Calcium
20%
Reactive Free Radicals
20%
Bioenergetic Failure
20%
Medicine and Dentistry
Doxorubicin
100%
Radical (Chemistry)
33%
Isotopes of Calcium
16%
Anticarcinogen
16%
Cancer
16%
Solid Malignant Neoplasm
16%
Mitochondrion
16%
Dilated Cardiomyopathy
16%
Congestive Heart Failure
16%
Cytopathology
16%
Drug Exposure
16%
Leukemia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Free Radical
33%
Leukemia
16%
Solid Malignant Neoplasm
16%
Anticarcinogen
16%
Congestive Cardiomyopathy
16%
Congestive Heart Failure
16%